Report cover image

Global Formulation Development Services Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 01, 2026
Length 213 Pages
SKU # APRC20817392

Description

The global Formulation Development Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Formulation Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Formulation Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Formulation Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Formulation Development Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Formulation Development Services include Coriolis Pharma, Aurigene Pharmaceutical Services, Adragos Pharma, Ascendia Pharmaceuticals, Dalton Pharma Services, Intertek, Suven Pharma, Agno Pharma and SGS SA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes



This report presents an overview of global market for Formulation Development Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Formulation Development Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Formulation Development Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Formulation Development Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Formulation Development Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Formulation Development Services revenue, projected growth trends, production technology, application and end-user industry.

Formulation Development Services Segment by Company

Coriolis Pharma
Aurigene Pharmaceutical Services
Adragos Pharma
Ascendia Pharmaceuticals
Dalton Pharma Services
Intertek
Suven Pharma
Agno Pharma
SGS SA
DPT Laboratories Ltd
MedPharm
Octavius Pharma
Pharmaron
CuriRx, Inc.
LGM pharma
Avivia BV
Corealis
Losan Pharma
Evonik Health Care
Lonza
Alcami
Scantox

Formulation Development Services Segment by Type

Food and Beverage Formula Development
Drug Formula Development
Cosmetic Formula Development
Health Care Product Formula Development
Others

Formulation Development Services Segment by Application

Large Enterprises
Small and Medium Enterprises

Formulation Development Services Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Formulation Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Formulation Development Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Formulation Development Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulation Development Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

213 Pages
1 Market Overview
1.1 Product Definition
1.2 Formulation Development Services Market by Type
1.2.1 Global Formulation Development Services Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Food and Beverage Formula Development
1.2.3 Drug Formula Development
1.2.4 Cosmetic Formula Development
1.2.5 Health Care Product Formula Development
1.2.6 Others
1.3 Formulation Development Services Market by Application
1.3.1 Global Formulation Development Services Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Large Enterprises
1.3.3 Small and Medium Enterprises
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Formulation Development Services Market Dynamics
2.1 Formulation Development Services Industry Trends
2.2 Formulation Development Services Industry Drivers
2.3 Formulation Development Services Industry Opportunities and Challenges
2.4 Formulation Development Services Industry Restraints
3 Global Growth Perspective
3.1 Global Formulation Development Services Market Perspective (2021-2032)
3.2 Global Formulation Development Services Growth Trends by Region
3.2.1 Global Formulation Development Services Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Formulation Development Services Market Size by Region (2021-2026)
3.2.3 Global Formulation Development Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Formulation Development Services Revenue by Players
4.1.1 Global Formulation Development Services Revenue by Players (2021-2026)
4.1.2 Global Formulation Development Services Revenue Market Share by Players (2021-2026)
4.1.3 Global Formulation Development Services Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Formulation Development Services Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Formulation Development Services Key Players Headquarters & Area Served
4.4 Global Formulation Development Services Players, Product Type & Application
4.5 Global Formulation Development Services Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Formulation Development Services Market CR5 and HHI
4.6.3 2025 Formulation Development Services Tier 1, Tier 2, and Tier 3
5 Formulation Development Services Market Size by Type
5.1 Global Formulation Development Services Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Formulation Development Services Revenue by Type (2021-2032)
5.3 Global Formulation Development Services Revenue Market Share by Type (2021-2032)
6 Formulation Development Services Market Size by Application
6.1 Global Formulation Development Services Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Formulation Development Services Revenue by Application (2021-2032)
6.3 Global Formulation Development Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Coriolis Pharma
7.1.1 Coriolis Pharma Company Information
7.1.2 Coriolis Pharma Business Overview
7.1.3 Coriolis Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.1.4 Coriolis Pharma Formulation Development Services Product Portfolio
7.1.5 Coriolis Pharma Recent Developments
7.2 Aurigene Pharmaceutical Services
7.2.1 Aurigene Pharmaceutical Services Company Information
7.2.2 Aurigene Pharmaceutical Services Business Overview
7.2.3 Aurigene Pharmaceutical Services Formulation Development Services Revenue and Gross Margin (2021-2026)
7.2.4 Aurigene Pharmaceutical Services Formulation Development Services Product Portfolio
7.2.5 Aurigene Pharmaceutical Services Recent Developments
7.3 Adragos Pharma
7.3.1 Adragos Pharma Company Information
7.3.2 Adragos Pharma Business Overview
7.3.3 Adragos Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.3.4 Adragos Pharma Formulation Development Services Product Portfolio
7.3.5 Adragos Pharma Recent Developments
7.4 Ascendia Pharmaceuticals
7.4.1 Ascendia Pharmaceuticals Company Information
7.4.2 Ascendia Pharmaceuticals Business Overview
7.4.3 Ascendia Pharmaceuticals Formulation Development Services Revenue and Gross Margin (2021-2026)
7.4.4 Ascendia Pharmaceuticals Formulation Development Services Product Portfolio
7.4.5 Ascendia Pharmaceuticals Recent Developments
7.5 Dalton Pharma Services
7.5.1 Dalton Pharma Services Company Information
7.5.2 Dalton Pharma Services Business Overview
7.5.3 Dalton Pharma Services Formulation Development Services Revenue and Gross Margin (2021-2026)
7.5.4 Dalton Pharma Services Formulation Development Services Product Portfolio
7.5.5 Dalton Pharma Services Recent Developments
7.6 Intertek
7.6.1 Intertek Company Information
7.6.2 Intertek Business Overview
7.6.3 Intertek Formulation Development Services Revenue and Gross Margin (2021-2026)
7.6.4 Intertek Formulation Development Services Product Portfolio
7.6.5 Intertek Recent Developments
7.7 Suven Pharma
7.7.1 Suven Pharma Company Information
7.7.2 Suven Pharma Business Overview
7.7.3 Suven Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.7.4 Suven Pharma Formulation Development Services Product Portfolio
7.7.5 Suven Pharma Recent Developments
7.8 Agno Pharma
7.8.1 Agno Pharma Company Information
7.8.2 Agno Pharma Business Overview
7.8.3 Agno Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.8.4 Agno Pharma Formulation Development Services Product Portfolio
7.8.5 Agno Pharma Recent Developments
7.9 SGS SA
7.9.1 SGS SA Company Information
7.9.2 SGS SA Business Overview
7.9.3 SGS SA Formulation Development Services Revenue and Gross Margin (2021-2026)
7.9.4 SGS SA Formulation Development Services Product Portfolio
7.9.5 SGS SA Recent Developments
7.10 DPT Laboratories Ltd
7.10.1 DPT Laboratories Ltd Company Information
7.10.2 DPT Laboratories Ltd Business Overview
7.10.3 DPT Laboratories Ltd Formulation Development Services Revenue and Gross Margin (2021-2026)
7.10.4 DPT Laboratories Ltd Formulation Development Services Product Portfolio
7.10.5 DPT Laboratories Ltd Recent Developments
7.11 MedPharm
7.11.1 MedPharm Company Information
7.11.2 MedPharm Business Overview
7.11.3 MedPharm Formulation Development Services Revenue and Gross Margin (2021-2026)
7.11.4 MedPharm Formulation Development Services Product Portfolio
7.11.5 MedPharm Recent Developments
7.12 Octavius Pharma
7.12.1 Octavius Pharma Company Information
7.12.2 Octavius Pharma Business Overview
7.12.3 Octavius Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.12.4 Octavius Pharma Formulation Development Services Product Portfolio
7.12.5 Octavius Pharma Recent Developments
7.13 Pharmaron
7.13.1 Pharmaron Company Information
7.13.2 Pharmaron Business Overview
7.13.3 Pharmaron Formulation Development Services Revenue and Gross Margin (2021-2026)
7.13.4 Pharmaron Formulation Development Services Product Portfolio
7.13.5 Pharmaron Recent Developments
7.14 CuriRx, Inc.
7.14.1 CuriRx, Inc. Company Information
7.14.2 CuriRx, Inc. Business Overview
7.14.3 CuriRx, Inc. Formulation Development Services Revenue and Gross Margin (2021-2026)
7.14.4 CuriRx, Inc. Formulation Development Services Product Portfolio
7.14.5 CuriRx, Inc. Recent Developments
7.15 LGM pharma
7.15.1 LGM pharma Company Information
7.15.2 LGM pharma Business Overview
7.15.3 LGM pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.15.4 LGM pharma Formulation Development Services Product Portfolio
7.15.5 LGM pharma Recent Developments
7.16 Avivia BV
7.16.1 Avivia BV Company Information
7.16.2 Avivia BV Business Overview
7.16.3 Avivia BV Formulation Development Services Revenue and Gross Margin (2021-2026)
7.16.4 Avivia BV Formulation Development Services Product Portfolio
7.16.5 Avivia BV Recent Developments
7.17 Corealis
7.17.1 Corealis Company Information
7.17.2 Corealis Business Overview
7.17.3 Corealis Formulation Development Services Revenue and Gross Margin (2021-2026)
7.17.4 Corealis Formulation Development Services Product Portfolio
7.17.5 Corealis Recent Developments
7.18 Losan Pharma
7.18.1 Losan Pharma Company Information
7.18.2 Losan Pharma Business Overview
7.18.3 Losan Pharma Formulation Development Services Revenue and Gross Margin (2021-2026)
7.18.4 Losan Pharma Formulation Development Services Product Portfolio
7.18.5 Losan Pharma Recent Developments
7.19 Evonik Health Care
7.19.1 Evonik Health Care Company Information
7.19.2 Evonik Health Care Business Overview
7.19.3 Evonik Health Care Formulation Development Services Revenue and Gross Margin (2021-2026)
7.19.4 Evonik Health Care Formulation Development Services Product Portfolio
7.19.5 Evonik Health Care Recent Developments
7.20 Lonza
7.20.1 Lonza Company Information
7.20.2 Lonza Business Overview
7.20.3 Lonza Formulation Development Services Revenue and Gross Margin (2021-2026)
7.20.4 Lonza Formulation Development Services Product Portfolio
7.20.5 Lonza Recent Developments
7.21 Alcami
7.21.1 Alcami Company Information
7.21.2 Alcami Business Overview
7.21.3 Alcami Formulation Development Services Revenue and Gross Margin (2021-2026)
7.21.4 Alcami Formulation Development Services Product Portfolio
7.21.5 Alcami Recent Developments
7.22 Scantox
7.22.1 Scantox Company Information
7.22.2 Scantox Business Overview
7.22.3 Scantox Formulation Development Services Revenue and Gross Margin (2021-2026)
7.22.4 Scantox Formulation Development Services Product Portfolio
7.22.5 Scantox Recent Developments
8 North America
8.1 North America Formulation Development Services Revenue (2021-2032)
8.2 North America Formulation Development Services Revenue by Type (2021-2032)
8.2.1 North America Formulation Development Services Revenue by Type (2021-2026)
8.2.2 North America Formulation Development Services Revenue by Type (2027-2032)
8.3 North America Formulation Development Services Revenue Share by Type (2021-2032)
8.4 North America Formulation Development Services Revenue by Application (2021-2032)
8.4.1 North America Formulation Development Services Revenue by Application (2021-2026)
8.4.2 North America Formulation Development Services Revenue by Application (2027-2032)
8.5 North America Formulation Development Services Revenue Share by Application (2021-2032)
8.6 North America Formulation Development Services Revenue by Country
8.6.1 North America Formulation Development Services Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Formulation Development Services Revenue by Country (2021-2026)
8.6.3 North America Formulation Development Services Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Formulation Development Services Revenue (2021-2032)
9.2 Europe Formulation Development Services Revenue by Type (2021-2032)
9.2.1 Europe Formulation Development Services Revenue by Type (2021-2026)
9.2.2 Europe Formulation Development Services Revenue by Type (2027-2032)
9.3 Europe Formulation Development Services Revenue Share by Type (2021-2032)
9.4 Europe Formulation Development Services Revenue by Application (2021-2032)
9.4.1 Europe Formulation Development Services Revenue by Application (2021-2026)
9.4.2 Europe Formulation Development Services Revenue by Application (2027-2032)
9.5 Europe Formulation Development Services Revenue Share by Application (2021-2032)
9.6 Europe Formulation Development Services Revenue by Country
9.6.1 Europe Formulation Development Services Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Formulation Development Services Revenue by Country (2021-2026)
9.6.3 Europe Formulation Development Services Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Formulation Development Services Revenue (2021-2032)
10.2 China Formulation Development Services Revenue by Type (2021-2032)
10.2.1 China Formulation Development Services Revenue by Type (2021-2026)
10.2.2 China Formulation Development Services Revenue by Type (2027-2032)
10.3 China Formulation Development Services Revenue Share by Type (2021-2032)
10.4 China Formulation Development Services Revenue by Application (2021-2032)
10.4.1 China Formulation Development Services Revenue by Application (2021-2026)
10.4.2 China Formulation Development Services Revenue by Application (2027-2032)
10.5 China Formulation Development Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Formulation Development Services Revenue (2021-2032)
11.2 Asia Formulation Development Services Revenue by Type (2021-2032)
11.2.1 Asia Formulation Development Services Revenue by Type (2021-2026)
11.2.2 Asia Formulation Development Services Revenue by Type (2027-2032)
11.3 Asia Formulation Development Services Revenue Share by Type (2021-2032)
11.4 Asia Formulation Development Services Revenue by Application (2021-2032)
11.4.1 Asia Formulation Development Services Revenue by Application (2021-2026)
11.4.2 Asia Formulation Development Services Revenue by Application (2027-2032)
11.5 Asia Formulation Development Services Revenue Share by Application (2021-2032)
11.6 Asia Formulation Development Services Revenue by Country
11.6.1 Asia Formulation Development Services Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Formulation Development Services Revenue by Country (2021-2026)
11.6.3 Asia Formulation Development Services Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Formulation Development Services Revenue (2021-2032)
12.2 SAMEA Formulation Development Services Revenue by Type (2021-2032)
12.2.1 SAMEA Formulation Development Services Revenue by Type (2021-2026)
12.2.2 SAMEA Formulation Development Services Revenue by Type (2027-2032)
12.3 SAMEA Formulation Development Services Revenue Share by Type (2021-2032)
12.4 SAMEA Formulation Development Services Revenue by Application (2021-2032)
12.4.1 SAMEA Formulation Development Services Revenue by Application (2021-2026)
12.4.2 SAMEA Formulation Development Services Revenue by Application (2027-2032)
12.5 SAMEA Formulation Development Services Revenue Share by Application (2021-2032)
12.6 SAMEA Formulation Development Services Revenue by Country
12.6.1 SAMEA Formulation Development Services Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Formulation Development Services Revenue by Country (2021-2026)
12.6.3 SAMEA Formulation Development Services Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.